rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
12
|
pubmed:dateCreated |
2005-11-28
|
pubmed:abstractText |
Pharmacokinetic data on glucosamine are scant, limiting the understanding of glucosamine sulfate mechanism of action in support of its treatment effects in osteoarthritis. This study investigated the oral pharmacokinetics and dose-proportionality of glucosamine after administration of the patented crystalline glucosamine sulfate in man.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1063-4584
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1041-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16168682-Administration, Oral,
pubmed-meshheading:16168682-Adult,
pubmed-meshheading:16168682-Analysis of Variance,
pubmed-meshheading:16168682-Biological Availability,
pubmed-meshheading:16168682-Chromatography, Liquid,
pubmed-meshheading:16168682-Cross-Over Studies,
pubmed-meshheading:16168682-Crystallization,
pubmed-meshheading:16168682-Dose-Response Relationship, Drug,
pubmed-meshheading:16168682-Drug Administration Schedule,
pubmed-meshheading:16168682-Female,
pubmed-meshheading:16168682-Glucosamine,
pubmed-meshheading:16168682-Half-Life,
pubmed-meshheading:16168682-Humans,
pubmed-meshheading:16168682-Male,
pubmed-meshheading:16168682-Spectrum Analysis
|
pubmed:year |
2005
|
pubmed:articleTitle |
Glucosamine oral bioavailability and plasma pharmacokinetics after increasing doses of crystalline glucosamine sulfate in man.
|
pubmed:affiliation |
Clinical Pharmacology Department, Rotta Research Laboratorium/Rottapharm, Monza, Italy. stefano.persiani@rotta.com
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|